Sridhar Balasubramanyan
University of Alberta
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Sridhar Balasubramanyan.
Pain | 2006
Van B. Lu; Timothy D. Moran; Sridhar Balasubramanyan; Kwai Alier; William F. Dryden; William F. Colmers; Peter A. Smith
Abstract Peripheral nerve injury promotes an enduring increase in the excitability of the spinal dorsal horn. This change, that likely underlies the development of chronic pain, may be a consequence of prolonged exposure of dorsal horn neurons to mediators such as neurotrophins, cytokines, and neurotransmitters. The long‐term effects of such mediators can be analyzed by applying them to spinal neurons in organotypic slice culture. To assess the validity of this approach, we established serum‐free, defined‐medium organotypic cultures (DMOTC) from E13‐14 prenatal rats. Whole‐cell recordings were made from neurons maintained in DMOTC for up to 42 days. These were compared with recordings from neurons of similar age in acute spinal cord slices from 15‐ to 45‐day‐old rats. Five cell types were defined in acute slices as ‘Tonic’, ‘Irregular’, ‘Delay’, ‘Transient’ or ‘Phasic’ according to their discharge patterns in response to depolarizing current. Although fewer ‘Phasic’ cells were found in cultures, the proportions of ‘Tonic’, ‘Irregular’, ‘Delay’, and ‘Transient’ were similar to those found in acute slices. GABAergic, glycinergic, and ‘mixed’ inhibition were observed in neurons in acute slices and DMOTC. Pure glycinergic inhibition was absent in 7d cultures but became more pronounced as cultures aged. This parallels the development of glycinergic inhibition in vivo. These and other findings suggest that fundamental developmental processes related to neurotransmitter phenotype and neuronal firing properties are preserved in DMOTC. This validates their use in evaluating the cellular mechanisms that may contribute to the development of chronic pain.
Neuroscience | 2016
Martin J. Stebbing; Sridhar Balasubramanyan; Peter A. Smith
The neuropathic pain that results from peripheral nerve injury is associated with alterations in the properties of neurons in the superficial spinal laminae. Chronic constriction injury (CCI) of the rat sciatic nerve increases excitatory synaptic drive to excitatory neurons in the substantia gelatinosa while limiting that to inhibitory neurons. Since the calcium-binding protein calbindin D-28K has been associated with excitatory neurons, we examined whether CCI altered the properties of neurons expressing calbindin-like immunoreactivity (Cal+). These account for 30% of the neurons in lamina I and II. Calbindin did not co-localize with any particular electrophysiological phenotype of neuron; in substantia gelatinosa, it was found in some tonic, delay, irregular, phasic and transient firing neurons and in some cells that displayed central, radial or vertical morphology. When neuronal phenotype was defined more precisely in terms of both morphology and electrophysiological properties, no strong correlation with calbindin expression was found. The frequency and amplitude of spontaneous excitatory postsynaptic currents (sEPSC) in calbindin negative (Cal-) neurons was greater than that in Cal+ neurons. CCI did not alter the proportion of Cal+ neurons in the dorsal horn. Although CCI promoted a fourfold increase in sEPSC frequency in Cal+ neurons, sEPSC amplitude was reduced by 22% and charge transfer per second was unchanged. Since synaptic drive to Cal+ neurons is weak and there is no firm correlation between neuronal phenotype and calbindin expression, it is doubtful whether these neurons play a major role in the generation of central sensitization.
Molecular Pain | 2018
Sascha R. A. Alles; Esperanza Garcia; Sridhar Balasubramanyan; Karen Jones; John R. Tyson; Twinkle Joy; Terrance P. Snutch; Peter A. Smith
Background Following peripheral nerve chronic constriction injury, the accumulation of the α2δ–1 auxiliary subunit of voltage-gated Ca2+ channels in primary afferent terminals contributes to the onset of neuropathic pain. Overexpression of α2δ–1 in Xenopus oocytes increases the opening properties of Cav1.2 L-type channels and allows Ca2+ influx at physiological membrane potentials. We therefore posited that L-type channels play a role in neurotransmitter release in the superficial dorsal horn in the chronic constriction injury model of neuropathic pain. Results Whole-cell recording from lamina II neurons from rats, subject to sciatic chronic constriction injury, showed that the L-type Ca2+ channel blocker, nitrendipine (2 µM) reduced the frequency of spontaneous excitatory postsynaptic currents. Nitrendipine had little or no effect on spontaneous excitatory postsynaptic current frequency in neurons from sham-operated animals. To determine whether α2δ–1 is involved in upregulating function of Cav1.2 L-type channels, we tested the effect of the α2δ–1 ligand, gabapentin (100 µM) on currents recorded from HEK293F cells expressing Cav1.2/β4/α2δ–1 channels and found a significant decrease in peak amplitude with no effect on control Cav1.2/β4/α2δ–3 expressing cells. In PC-12 cells, gabapentin also significantly reduced the endogenous dihydropyridine-sensitive calcium current. In lamina II, gabapentin reduced spontaneous excitatory postsynaptic current frequency in neurons from animals subject to chronic constriction injury but not in those from sham-operated animals. Intraperitoneal injection of 5 mg/kg nitrendipine increased paw withdrawal threshold in animals subject to chronic constriction injury. Conclusion We suggest that L-type channels show an increased contribution to synaptic transmission in lamina II dorsal horn following peripheral nerve injury. The effect of gabapentin on Cav1.2 via α2δ–1 may contribute to its anti-allodynic action.
Neurophysiology | 2007
Van B. Lu; Sridhar Balasubramanyan; James E. Biggs; Martin J. Stebbing; S. L. Gustafson; Kathryn G. Todd; Aaron Y. Lai; David Dawbarn; William F. Colmers; Klaus Ballanyi; Peter A. Smith
Chronic constriction injury (CCI) of the rat sciatic nerve increases the dorsal horn excitability. This “central sensitization” leads to behavioral manifestations analogous to those related to human neuropathic pain. We found, using whole-cell recording from acutely isolated spinal cord slices, that 7-to 10-day-long CCI increases excitatory synaptic drive to putative excitatory “delay”-firing neurons in the substantia gelatinosa but attenuates that to putative inhibitory “tonic”-firing neurons. A defined-medium organotypic culture (DMOTC) system was used to investigate the long-term actions of brain-derived neurotrophic factor (BDNF) as a possible instigator of these changes. When all five neuronal types found in the substantia gelatinosa were considered, BDNF and CCI produced similar patterns, or “footprints,” of changes across the whole population. This pattern was not seen with another putative “pain mediator,” interleukin 1β. Thus, BDNF decreased synaptic drive to “tonic” neurons and increased synaptic drive to “delay” neurons. Actions of BDNF on “delay” neurons were presynaptic and involved increased mEPSC frequency and amplitude without changes in the function of postsynaptic AMPA receptors. By contrast, BDNF exerted both pre-and post-synaptic actions on “ tonic” cells to reduce the mEPSC frequency and amplitude. These differential actions of BDNF on excitatory and inhibitory neurons contributed to a global increase in the dorsal horn network excitability as assessed by the amplitude of depolarization-induced increases in the intracellular [Ca2+]. Experiments with the BDNF-binding protein TrkB-d5 provided additional evidence for BDNF as a harbinger of neuropathic pain. Thus, the cellular processes altered by BDNF likely contribute to “central sensitization” and hence to the onset of neuropathic pain.
Journal of Neurophysiology | 2006
Sridhar Balasubramanyan; Patrick L. Stemkowski; Martin J. Stebbing; Peter A. Smith
The Journal of Physiology | 2009
Van B. Lu; James E. Biggs; Martin J. Stebbing; Sridhar Balasubramanyan; Kathryn G. Todd; Aaron Y. Lai; William F. Colmers; David Dawbarn; Klaus Ballanyi; Peter A. Smith
Molecular Pain | 2010
James E. Biggs; Van B. Lu; Martin J. Stebbing; Sridhar Balasubramanyan; Peter A. Smith
Journal of Neurophysiology | 2009
Yishen Chen; Sridhar Balasubramanyan; Aaron Y. Lai; Kathryn G. Todd; Peter A. Smith
Canadian Journal of Physiology and Pharmacology | 2003
Fuad A. Abdulla; Timothy D. Moran; Sridhar Balasubramanyan; Peter A. Smith
Archive | 2015
Ron C. Kupers; Xiao-Jun Xu; Sridhar Balasubramanyan; Patrick L. Stemkowski; Martin J. Stebbing; Peter A. Smith; Kimberly J. Dougherty; Shawn Hochman; Toshiki Endo; Teiji Tominaga; Lars Olson